.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Baxter
Citi
Argus Health
Moodys
Cipla
Mallinckrodt
QuintilesIMS
Chinese Patent Office

Generated: November 22, 2017

DrugPatentWatch Database Preview

Meloxicam - Generic Drug Details

« Back to Dashboard

What are the generic sources for meloxicam and what is the scope of meloxicam patent protection?

Meloxicam
is the generic ingredient in three branded drugs marketed by Taro, Aurobindo Pharma, Yung Shin Pharm, Breckenridge Pharm, Zydus Pharms Usa, Mylan, Roxane, Unichem, Strides Pharma, Cipla Ltd, Boehringer Ingelheim, Corepharma, Dr Reddys Labs Inc, Glenmark Generics, Iroko Pharms Llc, Yabao Pharm, Anda Repository, Teva Pharms, Sun Pharm Inds Inc, Puracap Pharm, Cr Double Crane, Lupin Pharms, and Apotex Inc, and is included in twenty-five NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Meloxicam has forty-four patent family members in thirty countries.

There are twenty-two drug master file entries for meloxicam. Fifty-four suppliers are listed for this compound.

Pharmacology for meloxicam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa
MELOXICAM
meloxicam
TABLET;ORAL077921-002Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
MELOXICAM
meloxicam
TABLET;ORAL077937-002Jul 19, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
MELOXICAM
meloxicam
TABLET;ORAL077937-001Jul 19, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
MELOXICAM
meloxicam
TABLET;ORAL077921-001Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Cr Double Crane
MELOXICAM
meloxicam
TABLET;ORAL078039-001Dec 14, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Puracap Pharm
MELOXICAM
meloxicam
TABLET;ORAL077938-001Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Yung Shin Pharm
MELOXICAM
meloxicam
TABLET;ORAL077918-002Dec 7, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
MELOXICAM
meloxicam
TABLET;ORAL077920-002Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Taro
MELOXICAM
meloxicam
TABLET;ORAL078102-002Nov 7, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
MELOXICAM
meloxicam
TABLET;ORAL077929-001Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: meloxicam

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,682,747 Process for preparing an oral suspension of a pharmaceutical substance► Subscribe
9,808,468Formulation of meloxicam► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: meloxicam

Country Document Number Estimated Expiration
European Patent Office0945131► Subscribe
Canada2951383► Subscribe
Singapore11201610179Q► Subscribe
Denmark1066029► Subscribe
Uruguay36172► Subscribe
European Patent Office3151835► Subscribe
China1150888► Subscribe
Germany59903023► Subscribe
Brazil9909189► Subscribe
World Intellectual Property Organization (WIPO)2015191595► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Deloitte
Cerilliant
Medtronic
Boehringer Ingelheim
Chinese Patent Office
Julphar
Colorcon
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot